Back to MNPR
GOLDMAN SACHS GROUP INC → MNPR
GOLDMAN SACHS GROUP INC MNPR Position History
Monopar Therapeutics Inc. • Healthcare
Quarters held
12
Latest value
$807K
Q3 2026
Peak value
$6.2M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $673K |
| Q3 2025 | $533K |
| Q4 2025 | $454K |
| Q4 2025 | $223K |
| Q4 2025 | $223K |
| Q4 2025 | $454K |
| Q1 2026 | $1.6M |
| Q1 2026 | $261K |
| Q2 2026 | $738K |
| Q2 2026 | $758K |
| Q3 2026 | $6.2M |
| Q3 2026 | $807K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $807K | 10.1K | — | — |
| Q3 2026 | $6.2M | 77.7K | — | — |
| Q2 2026 | $758K | 8.2K | — | — |
| Q2 2026 | $738K | 8.0K | — | — |
| Q1 2026 | $261K | 4.8K | — | — |
| Q1 2026 | $1.6M | 29.9K | — | — |
| Q4 2025 | $454K | 7.0K | — | — |
| Q4 2025 | $223K | 3.4K | — | — |
| Q4 2025 | $223K | 3.4K | — | — |
| Q4 2025 | $454K | 7.0K | — | — |
| Q3 2025 | $533K | 6.5K | — | — |
| Q1 2025 | $673K | 18.5K | — | — |